Add to Basket Bulk discount
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Cyclin-Dependent Kinase-Like 5 (CDKL5) (C-Term) antibody

Antigen

Cyclin-Dependent Kinase-Like 5 (CDKL5)

Synonyms ISSX, STK9, Stk9, BC038161, CDKL5, issx, stk9
Binding Site
Alternatives

C-Term

Clonality Polyclonal
Host
Alternatives

Rabbit

Reactivity
Alternatives

Human

Conjugate
Alternatives Un-conjugated
Application
Alternatives Western Blotting (WB), Immunohistochemistry (IHC), ELISA
1 reference available
Certificates ISO 9001:2008
Catalog no. ABIN391362
Quantity 0.1 mg  (0.25 mg/ml)
Price 280.50 $   Plus shipping costs $45.00
Bulk discount
Shipping to
Availability Will be delivered in 2 to 3 Business Days

Additional Information

Alternative name CDKL5 (STK9)
Gene ID 6792
UniProt O76039
Immunogen This CDKL5 (STK9) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 990~1019 amino acids from the C-terminal region of human STK9.
Isotype Ig
Description Other names: Serine/threonine protein kinase 9, Cyclin-dependent kinase-like 5
Characteristics Purified Rabbit Polyclonal Antibody (Pab)
Specificity This CDKL5 (STK9) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 990~1019 amino acids from the C-terminal region of human STK9.
Molecular Weight 115537 DA
Comments

Background: Defects in STK9, a dual-specificity serine/threonine kinase, are a cause of atypical Rett syndrome. Rett syndrome is an X-linked dominant disease. It is a progressive neurologic developmental disorder and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation, and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood. Rett syndrome due to CDKL5-associated mutations is characterized by a severe early-onset phenotype and atypical features such as infantile spasms.

Application Details

Application Notes The suggested dilution is: ELISA~~1:1,000 Western blotting~~1:100~500 Immunohistochemistry~~1:10~50
Concentration 0.25 mg/ml
Purification Purified
Buffer Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Storage Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles
Research Area Phospho-specific antibodies, Cell Signaling, Protein Modifications, Neurology, Cell Structure
Restrictions For Research Use only

Publications

Product Montini, Andolfi, Caruso et al.: "Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region." in: Genomics, Vol. 51, Issue 3, pp. 427-33, 1998 (PubMed).

Alternatives

Alternatives for antigen "Cyclin-Dependent Kinase-Like 5 (CDKL5)", type "Antibodies"
Hosts Rabbit (23)
Reactivities Human (23), Cow (Bovine) (18), Dog (Canine) (18), Horse (Equine) (18), Mouse (Murine) (18), Pig (Porcine) (18), Rat (Rattus) (18), Sheep (Ovine) (18)
Applications Immunofluorescence (IF) (15), Western Blotting (WB) (8), ELISA (5), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (5), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) (3), Immunoelectron Microscopy (IEM) (1)
Conjugates Alexa Fluor 350 (1), Alexa Fluor 488 (1), Alexa Fluor 555 (1), Alexa Fluor 647 (1), Biotin (1), Cy3 (1), Cy5 (1), Cy5.5 (1), Cy7 (1), FITC (1), Gold (1), HRP (1), PE (1), PE-Cy3 (1), PE-Cy5 (1), PE-Cy5.5 (1), PE-Cy7 (1), Un-conjugated (1)
Epitopes AA 401-500 (18), C-Term (4)